Statistics for Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery.
Total visits
| views | |
|---|---|
| Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery. | 152 |
Total visits per month
| views | |
|---|---|
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
File Visits
| views | |
|---|---|
| Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery.pdf | 116 |
Top country views
| views | |
|---|---|
| Germany | 24 |
| United Kingdom | 20 |
| United States | 15 |
| China | 8 |
| Singapore | 3 |
| South Korea | 2 |
| Canada | 1 |
| France | 1 |
| Poland | 1 |
Top city views
| views | |
|---|---|
| Changi | 3 |
| Kiez | 3 |
| New Haven | 3 |
| Beijing | 2 |
| Chapel Hill | 2 |
| Hefei | 2 |
| Seoul | 2 |
| Woodbridge | 2 |
| Brooklyn | 1 |
| Frankfurt Am Main | 1 |
| Montréal | 1 |
| Qinhuangdao | 1 |
| Tampa | 1 |
| Wilmington | 1 |
| Wyandotte | 1 |
| Yulee | 1 |